The risk for PD is correlated with inflammatory cytokine genes (i.e., tumor necrosis factor-α and interleukin-1β) polymorphisms and with cell-surface human leukocyte antigen2 (Crotty et al., 2020). The gene discussed is TNF; the disease is Parkinson disease.